866-997-4948(US-Canada Toll Free)

Cancer Therapeutics CRC Pty Ltd - Product Pipeline Review - 2013

Published By :

Global Markets Direct

Published Date : Jun 2013

Category :

Cancer

No. of Pages : 37 Pages


Global Market Directs pharmaceuticals report, Cancer Therapeutics CRC Pty Ltd Product Pipeline Review 2013 provides data on the Cancer Therapeutics CRC Pty Ltds research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. 

This report is built using data and information sourced from Global Markets Directs proprietary databases, Cancer Therapeutics CRC Pty Ltds corporate website, SEC filings, investor presentations and featured press releases, both from Cancer Therapeutics CRC Pty Ltd and industry-specific third party sources, put together by Global Markets Directs team. 

Scope

  • Cancer Therapeutics CRC Pty Ltd Brief Cancer Therapeutics CRC Pty Ltd overview including business description, key information and facts, and its locations and subsidiaries.
  • Review of current pipeline of Cancer Therapeutics CRC Pty Ltd human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
  • Product profiles for late stage and clinical stage products of Cancer Therapeutics CRC Pty Ltd with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones. 
  • Recent updates of the Cancer Therapeutics CRC Pty Ltds pipeline in the last quarter. 
  • Key discontinued and dormant projects. 
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate Cancer Therapeutics CRC Pty Ltds strategic position with total access to detailed information on its product pipeline. 
  • Assess the growth potential of Cancer Therapeutics CRC Pty Ltd in its therapy areas of focus. 
  • Identify new drug targets and therapeutic classes in the Cancer Therapeutics CRC Pty Ltds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. 
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. 
  • Exploit collaboration and partnership opportunities with Cancer Therapeutics CRC Pty Ltd.
  • Avoid Intellectual Property Rights related issues. 
  • Explore the dormant and discontinued projects of Cancer Therapeutics CRC Pty Ltd and identify potential opportunities in those areas.
Table of Contents

Table of Contents 2

List of Tables 4
List of Figures 4
Cancer Therapeutics CRC Pty Ltd Snapshot 5
Cancer Therapeutics CRC Pty Ltd Overview 5
Key Information 5
Key Facts 5
Cancer Therapeutics CRC Pty Ltd Research and Development Overview 6
Key Therapeutic Areas 6
Cancer Therapeutics CRC Pty Ltd Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products Monotherapy 10
Cancer Therapeutics CRC Pty Ltd Pipeline Products Glance 11
Cancer Therapeutics CRC Pty Ltd Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Cancer Therapeutics CRC Pty Ltd Drug Profiles 13
CTX-0294945 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
CTx-0357927 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
CTX-294886 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Drug Targeting E6AP 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Drug Targeting FAK 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Drug Targeting FAK, FLT3 And VEGFR3 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Drug Targeting ICMT 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Drug Targeting MOZ 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Drug Targeting PRMT5 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Drug Targeting SIAH 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Drug Targeting USP7 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Drug Targeting VEGFR3 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
hSSB1 Inhibitor 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Program Targeting Cancer 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Cancer Therapeutics CRC Pty Ltd Pipeline Analysis 30
Cancer Therapeutics CRC Pty Ltd Pipeline Products by Therapeutic Class 30
Cancer Therapeutics CRC Pty Ltd Pipeline Products by Route of Administration 31
Cancer Therapeutics CRC Pty Ltd Pipeline Products By Mechanism of Action 32
Cancer Therapeutics CRC Pty Ltd - Dormant Projects 34
Cancer Therapeutics CRC Pty Ltd Locations And Subsidiaries 35
Head Office 35

Appendix 36
Methodology 36
Coverage 36
Secondary Research 36
Primary Research 36
Expert Panel Validation 36
Contact Us 37
Disclaimer 37

List of Table


Cancer Therapeutics CRC Pty Ltd, Key Information 5
Cancer Therapeutics CRC Pty Ltd, Key Facts 5
Cancer Therapeutics CRC Pty Ltd Pipeline by Indication, 2013 8
Cancer Therapeutics CRC Pty Ltd Pipeline by Stage of Development, 2013 9
Cancer Therapeutics CRC Pty Ltd Monotherapy Products in Pipeline, 2013 10
Cancer Therapeutics CRC Pty Ltd Pre-Clinical, 2013 11
Cancer Therapeutics CRC Pty Ltd Discovery, 2013 12
Cancer Therapeutics CRC Pty Ltd Pipeline By Therapeutic Class, 2013 30
Cancer Therapeutics CRC Pty Ltd Pipeline By Route of Administration, 2013 31
Cancer Therapeutics CRC Pty Ltd Pipeline Products By Mechanism of Action, 2013 33
Cancer Therapeutics CRC Pty Ltd - Dormant Developmental Projects,2013 34

List of Chart


Cancer Therapeutics CRC Pty Ltd Pipeline by Indication, 2013 7
Cancer Therapeutics CRC Pty Ltd Pipeline by Stage of Development, 2013 9
Cancer Therapeutics CRC Pty Ltd Monotherapy Products in Pipeline, 2013 10
Cancer Therapeutics CRC Pty Ltd Pipeline By Therapeutic Class, 2013 30
Cancer Therapeutics CRC Pty Ltd Pipeline By Route of Administration, 2013 31
Cancer Therapeutics CRC Pty Ltd - Pipeline Products By Mechanism of Action, 2013 32

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *